| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President | President &CFO +1 more
3 companies
Scibetta James S serves as a Director at MTNB and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 5 buys and 10 sells. Those positions are worth an estimated $1.2M at current prices.
The biggest single holding is PCRX (~$1.1M) as President. The recent filings there lean toward selling, a net 96,966 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2019 | AQST Aquestive Therapeutics, Inc. | Director | Buy | 22,971 | $3.79 | $86,977.07 | +265.1% | |
| Sep 7, 2017 | MTNB Matinas Biopharma Holdings, Inc. | Director | Buy | 5,000 | $1.29 | $6,450.00 | +1.2% | |
| Jun 5, 2017 | PCRX Pacira Biosciences, Inc. | President | Sell | 1,966 | $43.32 | $85,169.09 | -7.3% | |
| May 15, 2017 | PCRX Pacira Biosciences, Inc. | President | Sale+OE | 20,000 | $51.20 | $1,024,000.00 | -42.5% | |
| Jan 17, 2017 | PCRX Pacira Biosciences, Inc. | President | Sale+OE | 20,000 | $38.53 | $770,698.26 | -42.5% | |
| Nov 15, 2016 | PCRX Pacira Biosciences, Inc. | President | Sale+OE | 20,000 | $36.50 | $730,000.00 | -42.5% | |
| Aug 15, 2016 | PCRX Pacira Biosciences, Inc. | President | Sale+OE | 25,000 | $45.21 | $1,130,250.00 | -48.0% | |
| Sep 11, 2015 | PCRX Pacira Biosciences, Inc. | SVP, Chief Financial Officer | Buy | 5,000 | $61.37 | $306,850.00 | +90.8% | |
| Feb 6, 2015 | PCRX Pacira Biosciences, Inc. | SVP, Chief Financial Officer | Sale+OE | 15,000 | $111.22 | $1,668,374.19 | -74.1% |